# FDA Inspection 965150 - Acadia Pharmaceuticals Inc. - February 17, 2016

Source: https://www.keypedia.com/records/fda_inspections/acadia-pharmaceuticals-inc/a5ee1d2d-f85e-40e7-a860-6147f71960c4
Source feed: FDA_Inspections

> FDA Inspection 965150 for Acadia Pharmaceuticals Inc. on February 17, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 965150
- Company Name: Acadia Pharmaceuticals Inc.
- Inspection Date: 2016-02-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1135361 - 2021-01-27](https://www.keypedia.com/records/fda_inspections/acadia-pharmaceuticals-inc/bd5a1d2d-4e13-4dd2-8bfe-a9d96c4ffa11)

Company: https://www.keypedia.com/companies/acadia-pharmaceuticals-inc/28c1a8c0-e128-4d10-ac29-27aa95b67b55

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c